233 related articles for article (PubMed ID: 33277547)
1. Targeting aurora kinases as a potential prognostic and therapeutical biomarkers in pediatric acute lymphoblastic leukaemia.
Moreira-Nunes CA; Mesquita FP; Portilho AJS; Mello Júnior FAR; Maués JHDS; Pantoja LDC; Wanderley AV; Khayat AS; Zuercher WJ; Montenegro RC; de Moraes-Filho MO; de Moraes MEA
Sci Rep; 2020 Dec; 10(1):21272. PubMed ID: 33277547
[TBL] [Abstract][Full Text] [Related]
2. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
Dos Santos EO; Carneiro-Lobo TC; Aoki MN; Levantini E; Bassères DS
Mol Cancer; 2016 Feb; 15():12. PubMed ID: 26842935
[TBL] [Abstract][Full Text] [Related]
3. Bcr-Abl activates AURKA and AURKB in chronic myeloid leukemia cells via AKT signaling.
Yang J; Ikezoe T; Nishioka C; Udaka K; Yokoyama A
Int J Cancer; 2014 Mar; 134(5):1183-94. PubMed ID: 23934627
[TBL] [Abstract][Full Text] [Related]
4. High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy.
Burgess EF; Livasy C; Trufan S; Hartman A; Guerreri R; Naso C; Clark PE; Grigg C; Symanowski J; Raghavan D
Urol Oncol; 2019 Dec; 37(12):900-906. PubMed ID: 31597600
[TBL] [Abstract][Full Text] [Related]
5. SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B.
Yu Z; Sun Y; She X; Wang Z; Chen S; Deng Z; Zhang Y; Liu Q; Liu Q; Zhao C; Li P; Liu C; Feng J; Fu H; Li G; Wu M
J Hematol Oncol; 2017 Jun; 10(1):115. PubMed ID: 28595628
[TBL] [Abstract][Full Text] [Related]
6. Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia.
Carlos JAEG; Lima K; Coelho-Silva JL; de Melo Alves-Paiva R; Moreno NC; Vicari HP; de Souza Santos FP; Hamerschlak N; Costa-Lotufo LV; Traina F; Machado-Neto JA
Cell Oncol (Dordr); 2020 Dec; 43(6):1191-1201. PubMed ID: 32857324
[TBL] [Abstract][Full Text] [Related]
7. Daurinol Enhances the Efficacy of Radiotherapy in Lung Cancer via Suppression of Aurora Kinase A/B Expression.
Woo JK; Kang JH; Shin D; Park SH; Kang K; Nho CW; Seong JK; Lee SJ; Oh SH
Mol Cancer Ther; 2015 Jul; 14(7):1693-704. PubMed ID: 25882311
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis identifies as a critical prognostic prediction gene in breast cancer.
Hu T; Wang X; Xia Y; Wu L; Ma Y; Zhou R; Zhao Y
Chin Med J (Engl); 2022 Sep; 135(18):2218-2231. PubMed ID: 36113844
[TBL] [Abstract][Full Text] [Related]
9. Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.
den Hollander J; Rimpi S; Doherty JR; Rudelius M; Buck A; Hoellein A; Kremer M; Graf N; Scheerer M; Hall MA; Goga A; von Bubnoff N; Duyster J; Peschel C; Cleveland JL; Nilsson JA; Keller U
Blood; 2010 Sep; 116(9):1498-505. PubMed ID: 20519624
[TBL] [Abstract][Full Text] [Related]
10. Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target.
Hartsink-Segers SA; Zwaan CM; Exalto C; Luijendijk MW; Calvert VS; Petricoin EF; Evans WE; Reinhardt D; de Haas V; Hedtjärn M; Hansen BR; Koch T; Caron HN; Pieters R; Den Boer ML
Leukemia; 2013 Mar; 27(3):560-8. PubMed ID: 22940834
[TBL] [Abstract][Full Text] [Related]
11. Genetic Interactions between the Aurora Kinases Reveal New Requirements for AURKB and AURKC during Oocyte Meiosis.
Nguyen AL; Drutovic D; Vazquez BN; El Yakoubi W; Gentilello AS; Malumbres M; Solc P; Schindler K
Curr Biol; 2018 Nov; 28(21):3458-3468.e5. PubMed ID: 30415701
[TBL] [Abstract][Full Text] [Related]
12. Spindle assembly checkpoint gene expression in childhood adrenocortical tumors (ACT): Overexpression of Aurora kinases A and B is associated with a poor prognosis.
Borges KS; Moreno DA; Martinelli CE; Antonini SR; de Castro M; Tucci S; Neder L; Ramalho LN; Seidinger AL; Cardinalli I; Mastellaro MJ; Yunes JA; Brandalise SR; Tone LG; Scrideli CA
Pediatr Blood Cancer; 2013 Nov; 60(11):1809-16. PubMed ID: 23788275
[TBL] [Abstract][Full Text] [Related]
13. Expression of Hippo signaling pathway and Aurora kinase genes in chronic myeloid leukemia.
Marsola APZC; Simões BP; Palma LC; Berzoti-Coelho MG; Burin SM; de Castro FA
Med Oncol; 2018 Jan; 35(3):26. PubMed ID: 29387948
[TBL] [Abstract][Full Text] [Related]
14. High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia.
Lucena-Araujo AR; de Oliveira FM; Leite-Cueva SD; dos Santos GA; Falcao RP; Rego EM
Leuk Res; 2011 Feb; 35(2):260-4. PubMed ID: 20732714
[TBL] [Abstract][Full Text] [Related]
15. Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA/B) inhibitors: Synthesis, biological evaluation and in silico insights.
Al-Sanea MM; Elkamhawy A; Paik S; Lee K; El Kerdawy AM; Syed Nasir Abbas B; Joo Roh E; Eldehna WM; Elshemy HAH; Bakr RB; Ali Farahat I; Alzarea AI; Alzarea SI; Alharbi KS; Abdelgawad MA
Bioorg Med Chem; 2020 Jul; 28(13):115525. PubMed ID: 32371117
[TBL] [Abstract][Full Text] [Related]
16. Reversine triggers mitotic catastrophe and apoptosis in K562 cells.
Rodrigues Alves AP; Machado-Neto JA; Scheucher PS; Paiva HH; Simões BP; Rego EM; Traina F
Leuk Res; 2016 Sep; 48():26-31. PubMed ID: 27447890
[TBL] [Abstract][Full Text] [Related]
17. p53 deficiency enhances mitotic arrest and slippage induced by pharmacological inhibition of Aurora kinases.
Marxer M; Ma HT; Man WY; Poon RY
Oncogene; 2014 Jul; 33(27):3550-60. PubMed ID: 23955083
[TBL] [Abstract][Full Text] [Related]
18. Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer.
Borah NA; Reddy MM
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915740
[TBL] [Abstract][Full Text] [Related]
19. Mitotic syndicates Aurora Kinase B (AURKB) and mitotic arrest deficient 2 like 2 (MAD2L2) in cohorts of DNA damage response (DDR) and tumorigenesis.
Marima R; Hull R; Penny C; Dlamini Z
Mutat Res Rev Mutat Res; 2021; 787():108376. PubMed ID: 34083040
[TBL] [Abstract][Full Text] [Related]
20. Aurora kinase B inhibits aurora kinase A to control maternal mRNA translation in mouse oocytes.
Aboelenain M; Schindler K
Development; 2021 Nov; 148(21):. PubMed ID: 34636397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
